Smart insulin pump could ease diabetes management for kidney patients on dialysis

NCT ID NCT07422532

Not yet recruiting Disease control Sponsor: Imperial College London Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether an automated insulin delivery system (the Omnipod 5) can help people with type 2 diabetes who are on dialysis achieve better blood sugar control. Half of the 84 participants will use the automated system, while the other half will continue their usual insulin injections. The goal is to see if the device improves glucose levels and quality of life over 12 weeks.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Omnipod 5 automated insulin delivery system
What this could lead to: If it works, this could offer a safer, easier way for people with type 2 diabetes on dialysis to manage their blood sugar without constant finger-prick tests.
What could go wrong: This is a small, early-stage trial with only 84 participants. The device is not yet proven for this specific group, and results may not apply to everyone. There is also a risk of device malfunction or low blood sugar.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC KIDNEY DISEASE 5D are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chronic renal failure syndrome end stage renal failure type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CHRONIC KIDNEY DISEASE 5D TYPE 2 DIABETES

Contacts and locations

Locations

Guys and St Thomas' Hospitals

London, United Kingdom
Hammersmith Hospital

London, United Kingdom
Manchester Royal Infirmary

Manchester, United Kingdom
Royal Derby Hospital

Derby, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.